How this company measures up on the fundamentals that matter
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers private duty nursing (PDN) services, which include in-home skilled nursing services to medically complex children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and non-clinical care, including support services and personal care services; and in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Five compliance checks based on AAOIFI standards — all must pass for ethical clearance
Trading at $7 against a fair value of $10, a 29% discount. Moderate competitive position. Fails ethical screen (Debt ratio). Ranks better than 86% of screened stocks.
Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data
Trading characteristics and market positioning
Balance sheet strength and cash generation — the foundation of long-term value
SEC Form 4 filings — what company insiders are buying and selling
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-20 | CUNNINGHAM PATRICK A | Officer | 125,000 | $948,538 | |
| 2026-02-19 | STEWART DEBORAH | Officer | 29,815 | $220,197 | |
| 2026-02-19 | BUCKHALTER MATTHEW | Chief Financial Officer | 36,030 | $266,097 | |
| 2026-02-19 | SHANER JEFFREY | Chief Executive Officer | 461,909 | $3,411,399 | |
| 2026-02-19 | REISZ EDWIN C | Officer | 162,043 | $1,196,758 | |
| 2026-02-19 | CUNNINGHAM PATRICK A | Officer | 49,160 | $363,068 | |
| 2026-02-13 | GANZI VICTOR F. | Director | 18,916 | — | |
| 2026-02-13 | WINDLEY RODNEY D | Director | 289,947 | — | |
| 2026-02-13 | RODGERS STEVEN E | Director | 18,916 | — | |
| 2026-02-13 | SHANER JEFFREY | Chief Executive Officer | 715,229 | — |
Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-14